AKT1 and major depressive disorder: Mechanistic studies have elucidated that AKT1 contributes to MDD through its regulation of neuroplasticity, modulation of neuroinflammatory pathways, and its influence on hypothalamic–pituitary–adrenal (HPA) axis activity [38].